BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11776785)

  • 1. [Mutations of several tumor suppressor genes in primary retinoblastoma].
    Huang Q; Tao Y; Yandell DW
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The status of p53 gene in the primary retinoblastoma].
    Huang Q
    Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):248-51. PubMed ID: 11835813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of p16INK4A and p15INK4B on human hepatocellular carcinoma cell proliferation and apoptosis].
    Qin Y; Liu JY; Li B; Peng WZ; Fu MD; Sun ZL; Sun ZF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):132-7. PubMed ID: 15079795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
    Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers.
    Miyamoto H; Kubota Y; Fujinami K; Dobashi Y; Kondo K; Yao M; Shuin T; Hosaka M
    Oncol Res; 1995; 7(7-8):327-30. PubMed ID: 8747595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
    Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Deletions and aberrant transcription of p16 and p15 genes in childhood acute lymphoblastic leukemia].
    Fu G; Lu C; Zhang R
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):366-8. PubMed ID: 11721435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
    IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormal methylation of several tumor suppressor genes in sporadic breast cancer].
    Zemliakova VV; Zhevlova AI; Strel'nikov VV; Liubchenko LN; Vishnevskaia IaV; Tret'iakova VA; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2003; 37(4):696-703. PubMed ID: 12942643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoblastoma gene: its role in cell cycle and cancer.
    Giordano A; Kaiser HE
    In Vivo; 1996; 10(2):223-7. PubMed ID: 8744804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between tumor suppressor gene p16 and Rb and early diagnosis of lung cancers].
    Ye Y; Su C; Wang D; Liu S; Liu Y; Liu B; Cao X; Shan X; Wu M
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):537-41, 30. PubMed ID: 11832104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The multiple tumor suppressor genes in human esophageal cancer].
    Li HC; Lu SX
    Zhonghua Yi Xue Za Zhi; 1994 Aug; 74(8):489-91, 519. PubMed ID: 7994660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene diagnosis and genetic counselling of Rb gene mutations in retinoblastoma patients and their family members].
    Huang Q; Dryja TP; Yandell DW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Apr; 15(2):65-8. PubMed ID: 9531640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
    Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
    Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.